Agilent Technologies, Inc

157.6 USD +0.66 USD ( +0.42% )

Agilent Technologies, Inc (NYSE:A)

Add A to Watchlist


Business Profile
Agilent Technologies, Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California. [ Read More ]


United States of America


Diagnostics & Research

Market Cap

47.71B USD

Enterprise Value

49.14B USD

Dividend Yield


Buyback Yield


Intrinsic Valuation

A Intrinsic Value
Intrinsic value based on company cash flows

The intrinsic value of one A stock under the base scenario is 79.84 USD. Compared to the current market price of 157.6 USD, the company's shares are overvalued by 49%.

Analyst Rating

Analyst Price Target
A Price Target

12 month price targets for A stock made by Wall Street analysts. The average price target is 180.67 USD with a high forecast of 210 USD and a low forecast of 161.6 USD.

161.6 USD
Upside 3%
180.67 USD
Upside 15%
210 USD
Upside 33%


Competitors Valuation Chart
Agilent Technologies, Inc Competitors

Competitors Valuation Table
Agilent Technologies, Inc Competitors

Shareholder Return

Stock Performance
A Price Statistics

A Market
1 Week +2% +1%
6 Months +15% +8%
1 Year +49% +31%
3 Years +156% +65%

Stock Price
A Price Chart


Forecasted Financials

Forecast of Future Revenue


Net Income
Forecast of Future Net Income


Agilent Technologies, Inc Revenue and Net Income forecasts made by Wall Street analysts.